Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Project Oncology®
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Shelina Ramnarine, PhD; John Mascarenhas, MD
- Shelina Ramnarine, PhD
- John Mascarenhas, MD
- Marina Kremyanskaya, MD
Improving Long-Term Adherence to CRC Screening Recommendations
Improving Long-Term Adherence to CRC Screening Recommendations
Clinician's Roundtable
Improving Long-Term Adherence to CRC Screening Recommendations
Brian P. McDonough, MD, FAAFP; David A. Lieberman, MD
- Brian P. McDonough, MD, FAAFP
- David A. Lieberman, MD
Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Project Oncology®
Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Charles Turck, PharmD, BCPS, BCCCP; Douglas A. Tremblay, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Douglas A. Tremblay, MD
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Project Oncology®
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Steve Jackson, PharmD; Apar Kishor Ganti, MD
- Steve Jackson, PharmD
- Apar Kishor Ganti, MD
- Thomas Marron, MD, PhD
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
CME/CE
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Amer Zeidan, MBBS; Ghayas Issa, MD
0.50 credits
- Amer Zeidan, MBBS
- Ghayas Issa, MD
0.50 credits
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
Kathleen N. Moore, MD; Ritu Salani, MD
1.00 program credit
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credit
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
Kathleen N. Moore, MD; Ritu Salani, MD
1.00 program credit
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credit
CME/CE Virtual Event
Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
Multiple dates available
0.75 credits

Medical News

Medical News
Mental Health Comorbidity Raises Acute Care Use in Cancer
08/17/2026
Read more
Medical News
BACE Added to Tislelizumab Improved Response in Bulky NSCLC
08/17/2026
Read more
Medical News
CT Body Composition Misses Cancer Nutritional Risk
08/17/2026
Read more
Medical News
SEER-22 Study Finds Mycosis Fungoides Survival Gaps
08/11/2026
Read more

CME/CE

Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
MinuteCE®
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
Kathleen N. Moore, MD; Ritu Salani, MD
1.00 program credit
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credit
MinuteCE®
Treatment Decisions That Matter: A Case-Based Discussion in Advanced Ovarian Cancer
Kathleen N. Moore, MD; Ritu Salani, MD
1.00 credit 5 episodes
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 credit 5 episodes
CME/CE Virtual Event
Targeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure
Multiple dates available
0.50 credits
CME/CE In-Person & Virtual Event
The CELMoD Shift: Translating Protein Degradation Science Into Practice-Changing Myeloma Care
December 11, 2026
New Orleans, Louisiana
1.50 credits

Clinical Practice

Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Project Oncology®
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Shelina Ramnarine, PhD; John Mascarenhas, MD
- Shelina Ramnarine, PhD
- John Mascarenhas, MD
- Marina Kremyanskaya, MD
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Project Oncology®
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Steve Jackson, PharmD; Apar Kishor Ganti, MD
- Steve Jackson, PharmD
- Apar Kishor Ganti, MD
- Thomas Marron, MD, PhD
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
CME/CE
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Amer Zeidan, MBBS; Ghayas Issa, MD
0.50 credits
- Amer Zeidan, MBBS
- Ghayas Issa, MD
0.50 credits
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Project Oncology®
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Guru P. Sonpavde, MD
- Guru P. Sonpavde, MD

Programs

Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Project Oncology®
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Shelina Ramnarine, PhD; John Mascarenhas, MD
- Shelina Ramnarine, PhD
- John Mascarenhas, MD
- Marina Kremyanskaya, MD
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
CME/CE
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Amer Zeidan, MBBS; Ghayas Issa, MD
0.50 credits
- Amer Zeidan, MBBS
- Ghayas Issa, MD
0.50 credits
CME/CE In-Person & Virtual Event
The CELMoD Shift: Translating Protein Degradation Science Into Practice-Changing Myeloma Care
December 11, 2026
New Orleans, Louisiana
1.50 credits
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Project Oncology®
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?